Increased expression of natural-killer-associated and activation antigens in multiple myeloma
✍ Scribed by M. Gonźlez; J. F. San Miguel; A. Gascon; M-J. Moro; J. M. Hernandez; F. Ortega; R. Jimenez; L. Guerras; M. Romero; F. Casanova; M. A. Sanz; J. A. Portero; A. Orfao
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 478 KB
- Volume
- 39
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Natural killer (NK) activity of peripheral lymphocytes was measured in 39 patients with multiple myeloma prior to and during interferon (IFN) therapy. NK activity increased in a majority of patients following the first injection of IFN and remained at an increased level during I year of
A 1-month-old boy with familial erythrophagocytic lymphohistiocytosis (FEL) had a barely detectable natural killer (NK) activity of 0% to 7% (median, 0.5%) with an effector/target ratio of 20:1. The number of Leu'/+ and Leull+ cells was within normal range. In terms of interleukin-2 (IL-2) receptor
## Abstract Killer‐immunoglobulin‐like receptors (KIR) or C‐type lectin‐like receptors are heterogeneously expressed on NK cells and small subsets of T cells and might provide a new diagnostic tool for LGL lymphoproliferations (LGLL). We investigated the diagnostic impact of these cell surface mole
The blood of multiple myeloma patients was examined for non-MHC-restricted cytotoxic lymphocytes. Four colour flow cytometry was used to phenotype the cells within a light scatter gate large enough to include all lymphocytes. NK and T cells were identified using CD16, CD56, and CD3 antibodies, and m